微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 1.95% | -71.32% | 163.51% | 27/52 | 2.24% | 诺泰生物 | 14.63% | 行业排名> |
| 2024-03-31 | 0.74% | -90.21% | -91.8% | 29/52 | 1.22% | 澳洋健康 | 30.56% | 行业排名> |
| 2023-12-31 | 9.02% | 633.33% | -36.88% | 15/52 | 3.83% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-09-30 | 14.29% | 107.1% | 110.15% | 7/52 | 6.78% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-06-30 | 6.8% | 35.73% | -10.05% | 13/52 | 1.93% | 澳洋健康 | 61.89% | 行业排名> |
| 2023-03-31 | 7.56% | 96.88% | 514.63% | 2/52 | 2.55% | 澳洋健康 | 48.34% | 行业排名> |
| 2022-12-31 | 1.23% | -87.07% | -82.17% | 36/52 | -0.52% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-09-30 | 6.9% | -41.97% | 37.72% | 28/52 | 11.21% | *ST宜康 | 75.53% | 行业排名> |
| 2022-06-30 | 5.01% | -26.54% | 30.47% | 22/52 | 5.46% | 博腾股份 | 39.77% | 行业排名> |
| 2022-03-31 | 3.84% | 2% | -59.62% | 15/52 | 3.09% | 睿智医药 | 41.16% | 行业排名> |
| 2021-12-31 | 9.51% | -25.47% | 39.44% | 29/52 | -6.4% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-06-30 | 6.82% | 2% | -46.55% | 18/52 | 2.32% | 澳洋健康 | 40.93% | 行业排名> |
| 2020-12-31 | 12.76% | 39.45% | 7.32% | 25/52 | 10.94% | 金域医学 | 43.58% | 行业排名> |
| 2020-09-30 | 11.89% | 2% | 29.95% | 14/52 | 7.83% | 金域医学 | 35.41% | 行业排名> |
| 2019-12-31 | 9.15% | -26.09% | -26.09% | 29/52 | 64.11% | 阳光诺和 | 26.2% | 行业排名> |
| 2018-12-31 | 12.38% | 323.97% | 323.97% | 20/52 | -0.5% | 金域医学 | 13.23% | 行业排名> |
| 2017-12-31 | 2.92% | 2% | 2% | 33/52 | 2.03% | 万邦医药 | 52.05% | 行业排名> |